pubmed-article:12085248 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:12085248 | lifeskim:mentions | umls-concept:C0006142 | lld:lifeskim |
pubmed-article:12085248 | lifeskim:mentions | umls-concept:C1522577 | lld:lifeskim |
pubmed-article:12085248 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
pubmed-article:12085248 | lifeskim:mentions | umls-concept:C1521761 | lld:lifeskim |
pubmed-article:12085248 | lifeskim:mentions | umls-concept:C0918012 | lld:lifeskim |
pubmed-article:12085248 | lifeskim:mentions | umls-concept:C0033522 | lld:lifeskim |
pubmed-article:12085248 | lifeskim:mentions | umls-concept:C0220901 | lld:lifeskim |
pubmed-article:12085248 | lifeskim:mentions | umls-concept:C1554080 | lld:lifeskim |
pubmed-article:12085248 | lifeskim:mentions | umls-concept:C1706198 | lld:lifeskim |
pubmed-article:12085248 | lifeskim:mentions | umls-concept:C0231449 | lld:lifeskim |
pubmed-article:12085248 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:12085248 | pubmed:dateCreated | 2002-6-26 | lld:pubmed |
pubmed-article:12085248 | pubmed:abstractText | In 1990, 215 patients with operable breast cancer were entered into a prospective study of the prognostic significance of five biochemical markers and 15 other factors (pathological/chronological/patient). After a median follow-up of 6.6 years, there were 77 recurrences and 77 deaths (59 breast cancer-related). By univariate analysis, patient outcome related significantly to 13 factors. By multivariate analysis, the most important of nine independent factors were: number of nodes involved, steroid receptors (for oestrogen or progestogen), age, clinical or pathological tumour size and grade. Receptors and grade exerted their influence only in the first 3 years. Progestogen receptors (immunohistochemical) and oestrogen receptors (biochemical) were of similar prognostic significance. The two receptors were correlated (r=+0.50, P=0.001) and displaced each other from the analytical model but some evidence for the additivity of their prognostic values was seen when their levels were discordant. | lld:pubmed |
pubmed-article:12085248 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12085248 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12085248 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12085248 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12085248 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12085248 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12085248 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12085248 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12085248 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12085248 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12085248 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12085248 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12085248 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12085248 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12085248 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12085248 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12085248 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12085248 | pubmed:language | eng | lld:pubmed |
pubmed-article:12085248 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12085248 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:12085248 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12085248 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12085248 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12085248 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:12085248 | pubmed:month | Jul | lld:pubmed |
pubmed-article:12085248 | pubmed:issn | 0007-0920 | lld:pubmed |
pubmed-article:12085248 | pubmed:author | pubmed-author:DixonJ MJM | lld:pubmed |
pubmed-article:12085248 | pubmed:author | pubmed-author:MillerW RWR | lld:pubmed |
pubmed-article:12085248 | pubmed:author | pubmed-author:BakerPP | lld:pubmed |
pubmed-article:12085248 | pubmed:author | pubmed-author:PrescottR JRJ | lld:pubmed |
pubmed-article:12085248 | pubmed:author | pubmed-author:HawkinsR ARA | lld:pubmed |
pubmed-article:12085248 | pubmed:author | pubmed-author:HulmeM JMJ | lld:pubmed |
pubmed-article:12085248 | pubmed:author | pubmed-author:ForsterTT | lld:pubmed |
pubmed-article:12085248 | pubmed:author | pubmed-author:McIntyreM AMA | lld:pubmed |
pubmed-article:12085248 | pubmed:author | pubmed-author:ChettyUU | lld:pubmed |
pubmed-article:12085248 | pubmed:author | pubmed-author:TesdaleA LAL | lld:pubmed |
pubmed-article:12085248 | pubmed:author | pubmed-author:KillenM EME | lld:pubmed |
pubmed-article:12085248 | pubmed:author | pubmed-author:JackW J LWJ | lld:pubmed |
pubmed-article:12085248 | pubmed:copyrightInfo | Copyright 2002 Cancer Research UK | lld:pubmed |
pubmed-article:12085248 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:12085248 | pubmed:day | 1 | lld:pubmed |
pubmed-article:12085248 | pubmed:volume | 87 | lld:pubmed |
pubmed-article:12085248 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:12085248 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:12085248 | pubmed:pagination | 8-14 | lld:pubmed |
pubmed-article:12085248 | pubmed:dateRevised | 2009-11-18 | lld:pubmed |
pubmed-article:12085248 | pubmed:meshHeading | pubmed-meshheading:12085248... | lld:pubmed |
pubmed-article:12085248 | pubmed:meshHeading | pubmed-meshheading:12085248... | lld:pubmed |
pubmed-article:12085248 | pubmed:meshHeading | pubmed-meshheading:12085248... | lld:pubmed |
pubmed-article:12085248 | pubmed:meshHeading | pubmed-meshheading:12085248... | lld:pubmed |
pubmed-article:12085248 | pubmed:meshHeading | pubmed-meshheading:12085248... | lld:pubmed |
pubmed-article:12085248 | pubmed:meshHeading | pubmed-meshheading:12085248... | lld:pubmed |
pubmed-article:12085248 | pubmed:meshHeading | pubmed-meshheading:12085248... | lld:pubmed |
pubmed-article:12085248 | pubmed:meshHeading | pubmed-meshheading:12085248... | lld:pubmed |
pubmed-article:12085248 | pubmed:meshHeading | pubmed-meshheading:12085248... | lld:pubmed |
pubmed-article:12085248 | pubmed:meshHeading | pubmed-meshheading:12085248... | lld:pubmed |
pubmed-article:12085248 | pubmed:meshHeading | pubmed-meshheading:12085248... | lld:pubmed |
pubmed-article:12085248 | pubmed:meshHeading | pubmed-meshheading:12085248... | lld:pubmed |
pubmed-article:12085248 | pubmed:meshHeading | pubmed-meshheading:12085248... | lld:pubmed |
pubmed-article:12085248 | pubmed:meshHeading | pubmed-meshheading:12085248... | lld:pubmed |
pubmed-article:12085248 | pubmed:year | 2002 | lld:pubmed |
pubmed-article:12085248 | pubmed:articleTitle | Outcome after extended follow-up in a prospective study of operable breast cancer: key factors and a prognostic index. | lld:pubmed |
pubmed-article:12085248 | pubmed:affiliation | University Department of Surgery, Royal Infirmary NHS Trust, Edinburgh EH3 9YW, UK. richardhawkins5@btinternet.com | lld:pubmed |
pubmed-article:12085248 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:12085248 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12085248 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12085248 | lld:pubmed |